ATXI Avenue Therapeutics, Inc.

Fundamentals / CIK 0001644963 / USD

Avenue Therapeutics, Inc. reported $1.40M in revenue and a net loss of $2.79M for the fiscal year ended December 31, 2025, with a -204.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATXI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$4.12M$2.06M$0-$24.34MFY 2016 Net Income: -$3.18M2016FY 2017 Net Income: -$12.26M2017FY 2018 Net Income: -$21.55M2018FY 2019 Net Income: -$25.91M2019FY 2020 Net Income: -$5.15M2020FY 2021 Net Income: -$3.73M2021FY 2022 Net Income: -$3.55M2022FY 2023 Net Income: -$10.38M2023FY 2024 Revenue: $0FY 2024 Net Income: -$11.65M2024FY 2025 Revenue: $1.40MFY 2025 Net Income: -$2.91M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.40M $0 -- -- -- -- -- -- -- --
Research & Development $1.04M $6.64M $6.13M $2.70M $1.25M $2.87M $22.19M $17.70M $6.70M $1.33M
Total Operating Expenses $4.49M $11.28M -- -- -- -- -- -- -- --
Operating Income -$3.08M -$11.28M -$14.54M -$8.04M -$3.74M -$5.21M -$26.27M -$21.82M -$11.42M -$2.38M
Interest Income $121K $176K $126K $20K $7.0K $62K $357K $93K $88K $0
Interest Expense -- -- -- -- -- -- -- $0 $294K $420K
Income Tax Expense $2.0K $0 $0 $0 -- -- -- -- -- --
Net Income -$2.91M -$11.65M -$10.38M -$3.55M -$3.73M -$5.15M -$25.91M -$21.55M -$12.26M -$3.18M
Basic EPS -$0.93 -$15.79 -$73.48 -$1.63 -$0.22 -$0.31 -$1.65 -$2.11 -$1.85 -$1.11
Diluted EPS -- -- -- -- -$0.22 -$0.31 -$1.65 -$2.11 -$1.85 -$1.11
Basic Shares Outstanding 3.1M 1.3M 141.2K 2.2M 1.1M 16.5M 15.7M 10.2M 6.6M 2.9M
Diluted Shares Outstanding -- -- -- 2.2M 1.1M 16.5M 15.7M 10.2M 6.6M 2.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 -- -- $0 $1.40M -- --
Research & Development $212K $247K $200K $257K $177K $192K $411K $565K
Total Operating Expenses $704K $707K -- -- $724K $1.11M -- --
Operating Income -$704K -$707K -$714K -$752K -$724K $297K -$1.91M -$1.60M
Interest Income $13K $17K $18K $25K $34K $31K $32K $24K
Net Income -$691K -$690K -$695K -$709K -$683K $335K -$1.85M -$1.54M
Basic EPS -$0.20 -$0.21 -$0.21 -- -$0.21 $0.11 -$0.62 --
Basic Shares Outstanding 3.5M 3.3M 3.3M -- 3.2M 3.2M 3.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $2.85M $2.59M $1.78M $6.71M $3.76M $3.13M $8.74M $2.67M $11.78M $197K
Short-Term Investments -- -- -- -- -- -- -- $0 $10.00M $0
Cash & Short-Term Investments $2.85M $2.59M $1.78M $6.71M $3.76M $3.13M $8.74M $2.67M $21.78M $197K
Total Current Assets -- -- -- -- $3.96M $3.25M -- -- -- --
Total Non-Current Assets -- -- -- -- $0 $0 -- -- -- --
Total Assets $2.93M $2.67M $1.85M $6.84M $3.96M $3.25M $8.91M $4.53M $22.17M $197K
Accounts Payable -- $155K $78K $129K $304K $143K $354K $3.09M $1.54M $334K
Total Current Liabilities $1.10M $816K $1.20M $3.58M $509K $886K $2.12M $5.16M $2.79M $6.42M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $2.03M
Total Liabilities $1.10M $816K $1.20M $3.58M $509K $886K $2.12M $5.16M $2.79M $8.45M
Common Stock $0 $0 $3.0K $0 $2.0K $2.0K $2.0K $1.0K $1.0K $1.0K
Retained Earnings -$105.5M -$102.6M -$90.93M -$80.55M -$77.00M -$73.27M -$68.12M -$42.21M -$20.66M -$8.40M
Total Stockholders' Equity $1.83M $2.80M $1.58M $3.90M $3.45M $2.36M $6.80M -$631K $19.38M -$8.25M
Total Equity $1.83M $1.86M $654K $3.27M $3.45M $2.36M $6.80M -$631K $19.38M -$8.25M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $1.52M $1.94M $2.42M $2.85M $3.71M $3.33M $3.50M $2.59M
Cash & Short-Term Investments $1.52M $1.94M $2.42M $2.85M $3.71M $3.33M $3.50M $2.59M
Total Assets $1.53M $1.98M $2.47M $2.93M $3.73M $4.16M $3.59M $2.67M
Accounts Payable -- -- -- -- -- -- -- $155K
Total Current Liabilities $1.60M $1.41M $1.27M $1.10M $1.42M $1.33M $1.26M $816K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $1.60M $1.41M $1.27M $1.10M $1.42M $1.33M $1.26M $816K
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$107.6M -$106.9M -$106.2M -$105.5M -$104.8M -$104.1M -$104.4M -$102.6M
Total Stockholders' Equity -$75K $569K $1.20M $1.83M $3.56M $4.06M $3.51M $2.80M
Total Equity -$75K $569K $1.20M $1.83M $2.30M $2.83M $2.33M $1.86M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$2.95M -$11.70M -$10.49M -$3.60M -$3.73M -$5.15M -$25.91M -$21.55M -$12.26M -$3.18M
Stock-Based Compensation $665K $1.24M $906K $649K $442K $710K $1.84M $1.54M $604K $28K
Operating Cash Flow -$1.83M -$9.03M -$9.45M -$7.60M -$3.75M -$4.61M -$26.26M -$18.22M -$6.80M -$1.63M
Purchases of Investments -- -- -- -- -- $0 -$5.00M $0 -$10.00M $0
Investing Cash Flow -- $0 -$3.00M $0 -- -$1.00M $0 $10.00M -$10.00M $0
Common Stock Issued $2.09M $1.62M $0 -- $5.04M $0 $35.00M $0 $37.95M $0
Share Repurchases -- -- $0 -$1.10M -- -- -- -- -- --
Financing Cash Flow $2.09M $9.84M $7.53M $10.54M $4.38M $0 $32.33M -$895K $28.39M $1.81M
Net Change in Cash $261K $811K -$4.92M $2.94M $631K -$5.61M $6.07M -$9.11M -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$691K -$690K -$695K -$726K -$692K $329K -$1.86M -$1.56M
Stock-Based Compensation $47K $61K $61K $142K $163K $175K $185K $522K
Operating Cash Flow -$422K -$475K -$438K -$854K $383K -$176K -$1.19M -$764K
Common Stock Issued $0 $0 $0 $0 $0 $0 $2.09M $761K
Financing Cash Flow $0 $0 $0 $0 $0 $0 $2.09M $761K
Net Change in Cash -$422K -$475K -$438K -$854K $383K -$176K $908K -$3.0K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -219.6% -- -- -- -- -- -- -- -- --
Net Profit Margin -207.2% -- -- -- -- -- -- -- -- --
Return on Equity (ROE) -158.8% -416.6% -655.9% -91.0% -108.1% -218.4% -381.0% -- -63.3% --
Return on Assets (ROA) -99.2% -436.1% -560.9% -51.9% -94.2% -158.7% -290.6% -476.2% -55.3% -1612.7%
Current Ratio -- -- -- -- 7.78x 3.66x -- -- -- --
Quick Ratio 2.60x 3.18x 1.49x 1.87x 7.39x 3.53x 4.13x 0.52x 7.81x 0.03x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -488.0% -146.2% -158.8% -105.3% -151.2% -261.1% -416.6%
Return on Assets (ROA) -182.0% -140.5% -71.0% -99.2% -100.5% -147.5% -255.0% -436.1%
Quick Ratio 0.95x 1.38x 1.90x 2.60x 2.61x 2.50x 2.77x 3.18x
Revenue Growth (YoY) -- -100.0% -- -- -- -- -- --
Operating Income Growth (YoY) -- -338.0% -- -- -- -- -- --
Net Income Growth (YoY) -- -306.0% -- -- -- -- -- -341.2%
EPS Growth (YoY) -- -290.9% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -210.2% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001644963) · from March 31, 2016 Data through September 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal